Somatostatin Receptors in Proliferating Endothelium
Author Information
Author(s): R L Adams, I P Adams, S W Lindow, W Zhong, S L Atkin
Primary Institution: University of Hull Postgraduate Medical School
Hypothesis
The study aims to determine whether there is a change in somatostatin receptor expression in proliferating vs quiescent human umbilical endothelial cells in vitro.
Conclusion
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelial cells, suggesting a role in angiogenesis.
Supporting Evidence
- Sst 2 and 5 were found to be preferentially expressed in proliferating HUVECs.
- Immunostaining confirmed the presence of sst 2 and 5 in proliferating but not quiescent cells.
- Somatostatin analogues significantly inhibited HUVEC proliferation in a dose-dependent manner.
Takeaway
The study found that certain receptors are more active in growing blood vessel cells, which could help us understand how to control blood vessel growth in diseases.
Methodology
The study involved culturing human umbilical vein endothelial cells (HUVECs) and analyzing their receptor expression and cell cycle progression using flow cytometry and quantitative PCR.
Potential Biases
Potential variability in receptor expression among different patient-derived HUVEC lines could introduce bias.
Limitations
The study's findings may not be generalizable beyond the specific cell lines used.
Participant Demographics
HUVECs were derived from human umbilical cords obtained from different patients.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website